Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A

5(55.6%)

Early Phase 1

2(22.2%)

Phase 1

1(11.1%)

Phase 2

1(11.1%)

9Total

N/A(5)

Early Phase 1(2)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07355491Recruiting

Performance Evaluation of Dream OCT: AP Study

Role: collaborator

NCT07229001Not ApplicableEnrolling By Invitation

Treating Meibomian Gland Disease in a Pediatric Population

Role: lead

NCT05509608Early Phase 1Enrolling By Invitation

Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects

Role: collaborator

NCT04418999Early Phase 1Completed

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Role: lead

NCT06549010Not ApplicableRecruiting

Perimetric Testing With Virtual Reality

Role: collaborator

NCT06029530Phase 1Withdrawn

Delaying the Onset of Nearsightedness Until Treatment Study

Role: collaborator

NCT03465748Not ApplicableCompleted

Effectiveness of Orthokeratology in Myopia Control

Role: lead

NCT02472223Not ApplicableCompleted

Reducing Adenoviral Patient Infected Days

Role: collaborator

NCT03417505Not ApplicableCompleted

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Role: collaborator

NCT02623543Phase 2Unknown

Effectiveness of Orthokeratology in Decreasing Myopic Progression in a Young Adult Population Enrolled in a Professional Optometric Curriculum

Role: lead

All 10 trials loaded